Literature DB >> 2065712

Effects of the analgesic agent tramadol in normal and arthritic rats: comparison with the effects of different opioids, including tolerance and cross-tolerance to morphine.

V Kayser1, J M Besson, G Guilbaud.   

Abstract

The effects of the analgesic agent tramadol (0.1-1 mg/kg i.v.) were compared to those of the mixed agonist-antagonist analgesics nalbuphine (1 mg/kg i.v.) and buprenorphine (3 micrograms/kg i.v.) in the vocalization threshold to paw pressure test. Normal and Freund's adjuvant-induced arthritic rats were used. We have shown previously that these animals used as a model of clinical pain exhibit an enhanced sensitivity to morphine (0.1-1 mg/kg i.v.), with a rapid development of tolerance after repetitive low doses, a response not observed in normal rats. In the present study, the antinociceptive effects of tramadol, buprenorphine and nalbuphine were enhanced (by 2- to 5-fold) in arthritic compared to normal rats. In this model, these effects were significantly reduced by a dose of naloxone (0.1 mg/kg i.v.) that completely antagonized the effect of morphine. In this model, the antinociceptive effect of tramadol (1 mg/kg i.v.) was comparable to that of nalbuphine (1 mg/kg i.v.), buprenorphine (3 micrograms/kg i.v.) and morphine (1 mg/kg i.v.). Repeated administration of low doses of tramadol twice daily for 4 days to arthritic rats did not induce tolerance, in contrast to nalbuphine, buprenorphine, and morphine. In addition, no cross-tolerance between tramadol and morphine was observed in these animals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065712     DOI: 10.1016/0014-2999(91)90379-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Effects of prolonged treatment with the opiate tramadol on prodynorphin gene expression in rat CNS.

Authors:  Sanzio Candeletti; Giuseppe Lopetuso; Rosalia Cannarsa; Chiara Cavina; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 2.  [Pharmacology of tramadol].

Authors:  P Dayer; J Desmeules; L Collart
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 3.  A risk-benefit assessment of tramadol in the management of pain.

Authors:  L Radbruch; S Grond; K A Lehmann
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

Review 4.  Pharmacology and clinical experience with tramadol in osteoarthritis.

Authors:  W A Katz
Journal:  Drugs       Date:  1996       Impact factor: 9.546

5.  A comparison of epidural tramadol and epidural morphine for postoperative analgesia.

Authors:  A Baraka; S Jabbour; M Ghabash; A Nader; G Khoury; A Sibai
Journal:  Can J Anaesth       Date:  1993-04       Impact factor: 5.063

Review 6.  Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states.

Authors:  C R Lee; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

7.  Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro.

Authors:  B Driessen; W Reimann; H Giertz
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

8.  [Systemic clonidine versus opioids in postoperative analgesia-A randomized double-blind study.].

Authors:  M Tryba; M Zenz
Journal:  Schmerz       Date:  1992-09       Impact factor: 1.107

Review 9.  The pharmacology of tramadol.

Authors:  P Dayer; L Collart; J Desmeules
Journal:  Drugs       Date:  1994       Impact factor: 9.546

10.  Tramadol extended-release in the management of chronic pain.

Authors:  Bill McCarberg
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.